Analgesics in Russia

Table of Contents

• List of Contents and Tables
• OTC HEALTHCARE IN RUSSIA
• Executive Summary
• Dlo Crises Causes Stagnation in the Russian Pharmaceutical Market
• New Registration Rules Lead To Cuts in Imports
• Generics Continues To Be Predominant in Russia
• Domestic Pharmaceutical Giant Among the Market Leaders
• Opportunities for Growth
• Key Trends and Developments
• Lifestyles Improve, Although Life Expectancy Remains Low
• Self-medication
• Growth Enabled by Many Mergers and Acquisitions
• Private Label Gains Ground
• Retailer Chains Record Intensive and Extensive Growth
• City Key Trends and Developments
• Moscow
• St Petersburg
• Market Indicators
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2002-2007
  • Table 2 Life Expectancy at Birth 2002-2007
• Market Data
  • Table 3 Sales of OTC Healthcare by Sector: Value 2002-2007
  • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2002-2007
  • Table 5 Sales of OTC Healthcare by City: Value 2002-2007
  • Table 6 Sales of OTC Healthcare by City: % Value Growth 2002-2007
  • Table 7 OTC Healthcare Company Shares by Value 2003-2007
  • Table 8 OTC Healthcare Brand Shares by Value 2004-2007
  • Table 9 Sales of OTC Healthcare by Distribution Format: % Analysis 2002-2007
  • Table 10 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2007
  • Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2007-2012
  • Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2007-2012
  • Table 13 Forecast Sales of OTC Healthcare by City: Value 2007-2012
  • Table 14 Forecast Sales of OTC Healthcare by City: % Value Growth 2007-2012
• Appendix
• OTC Registration and Classification
• De-listing Or De-reimbursement
• Advertising
• Packaging and Labelling
• Vitamins and Dietary Supplements Registration and Classification
• Generics
• Switches
  • Summary 1 OTC Healthcare Switches 2007
• Definitions
  • Summary 2 Research Sources
• LOCAL COMPANY PROFILES - RUSSIA
• Akrikhin Oao
• Strategic Direction
• Key Facts
  • Summary 3 Akrikhin OAO: Key Facts
  • Summary 4 Akrikhin OAO: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 5 Akrikhin OAO: Competitive Position 2007
• Berlin Chemie Russia
• Strategic Direction
• Key Facts
  • Summary 6 Berlin Chemie/ Menarini Group: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 7 Berlin Chemie/Menarini group : Competitive Position 2007
• GlaxoSmithKline Plc
• Strategic Direction
• Key Facts
  • Summary 8 GlaxoSmithKline PLC: Key Facts
• Company Background
• Production
• Competitive Positioning
  • Summary 9 GlaxoSmithKline PLC: Competitive Position 2007
• Novartis AG
• Strategic Direction
• Key Facts
  • Summary 10 Novartis AG : Key Facts
  • Summary 11 Novartis AG: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 12 Novartis AG: Competitive Position 2007
• Otechestvennye Lekarstva Oao
• Strategic Direction
• Key Facts
  • Summary 13 Otechestvennye Lekarstva Holding: Key Facts
  • Summary 14 Otechestvennye Lekarstva Holding: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 15 Otechestvennye Lekarstva Holding: Competitive Position 2007
• Pharmstandard Group
• Strategic Direction
• Key Facts
  • Summary 16 Pharmstandard Group: Key Facts
  • Summary 17 Pharmstandard Group: Operational Indicators
• Company Background
• Production
  • Summary 18 Pahrmstandard Group : Production Statistics 2007
• Competitive Positioning
  • Summary 19 Pharmstandard: Competitive Position 2007
• Ranbaxy Laboratories Ltd
• Strategic Direction
• Key Facts
  • Summary 20 Ranbaxy Laboratories limited: Key Facts
  • Summary 21 Ranbaxy Laboratories limited: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 22 Ranbaxy ZAO: Competitive Position 2007
• Sanofi-aventis
• Strategic Direction
• Key Facts
  • Summary 23 Sanofi-Aventis: Key Facts
  • Summary 24 Sanofi-Aventis: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 25 Sanofi-Aventis: Competitive Position 2007
• Stada Arzneimittel AG
• Strategic Direction
• Key Facts
  • Summary 26 Stada Arzneimittel AG: Key Facts
  • Summary 27 Stada Arzneimittel AG: Operational Indicators
• Company Background
• Production
• Competitive Positioning
  • Summary 28 Stada Arzneimittel AG: Competitive Position 2007
• Veropharm Zao
• Strategic Direction
• Key Facts
  • Summary 29 Veropharm OAO: Key Facts
  • Summary 30 Veropharm OAO: Operational Indicators
• Company Background
• Production
  • Summary 31 Veropharm OAO: Production Statistics 2006
• Competitive Positioning
  • Summary 32 Veropharm OAO: Competitive Position 2007
• ANALGESICS IN RUSSIA
• Headlines
• Trends
• Competitive Landscape
• Prospects
• Sector Data
  • Table 15 Sales of Analgesics by Subsector: Value 2002-2007
  • Table 16 Sales of Analgesics by Subsector: % Value Growth 2002-2007
  • Table 17 Herbal vs Standard Topical Analgesics 2002-2007
  • Table 18 Topical Analgesics by Format: % Value Breakdown 2004-2007
  • Table 19 Analgesics Company Shares by Value 2003-2007
  • Table 20 Analgesics Brand Shares by Value 2004-2007
  • Table 21 Forecast Sales of Analgesics by Subsector: Value 2007-2012
  • Table 22 Forecast Sales of Analgesics by Subsector: % Value Growth 2007-2012
• Analgesics Russia